首页> 外文期刊>Journal of Community Hospital Internal Medicine Perspectives >Oscillating hypothyroidism and hyperthyroidism - a case-based review
【24h】

Oscillating hypothyroidism and hyperthyroidism - a case-based review

机译:甲状腺功能减退症和甲状腺功能亢进症的病例分析

获取原文
           

摘要

Objective/Background: To discuss a unique clinical entity where inappropriate activity of inhibitory and stimulatory thyroid antibodies resulted in alternating hypothyroidism and hyperthyroidism.Methods: We report the clinical history, laboratory data, and results of imaging studies, along with the pathophysiological mechanism and the subsequent treatment in a patient with fluctuating thyroid functional status.Results: A 52-year-old female was treated for hypothyroidism for more than two decades. She started having symptoms of hyperthyroidism along with a suppressed thyroid-stimulating hormone (TSH). She continued to have persistent symptoms despite stopping her levothyroxine. Her free T3 and T4 were elevated along with an increased radioactive uptake scan. She was diagnosed with Graves’ disease and started on methimazole, which relieved her symptoms for a few months. Subsequently, her TSH began to rise beyond expected level, her hypothyroid symptoms reappeared, and methimazole was discontinued. Following this, she again developed symptoms of hyperthyroidism and thyroid values revealed an undetectable TSH. She had at least two such documented cycles of hyperthyroidism alternating with hypothyroidism. She was eventually treated with radioactive iodine ablation followed by levothyroxine replacement. Swinging dominance of TSH-blocking autoantibodies (TBAb) and thyroid-stimulating autoantibodies (TSAb) triggered by methimazole and levothyroxine, respectively, is likely the underlying mechanism.Conclusions: Physicians should be vigilant to the phenomenon of spontaneous conversion of hypothyroidism to hyperthyroidism, or vice versa, in a subset of patients with autoimmune thyroid disease. Repeated assessment of thyroid function along with measurement of TBAb and TSAb are invaluable in identifying this rare clinical entity.
机译:目的/背景:探讨一种独特的临床实体,其中抑制性和刺激性甲状腺抗体的不适当活动导致甲状腺功能减退和甲状腺功能亢进交替发生。方法:我们报告其临床病史,实验室数据和影像学研究结果,以及其病理生理机制和治疗方法。结果:一名52岁的女性因甲状腺功能减退症接受了超过二十年的治疗。她开始出现甲状腺功能亢进的症状,同时甲状腺刺激激素(TSH)受抑制。尽管停止服用左甲状腺素,她仍然持续出现症状。她的游离T3和T4随放射性摄取扫描的增加而升高。她被诊断出患有Graves病,并开始服用甲met咪唑,缓解了几个月的症状。随后,她的TSH开始升高到超出预期的水平,甲状腺功能减退的症状再次出现,并停用了他巴唑。此后,她再次出现甲状腺功能亢进的症状,甲状腺值显示无法检测到TSH。她至少有两个这样的甲状腺功能亢进与甲状腺功能低下交替的周期。最终她接受了放射性碘消融治疗,然后更换了左甲状腺素。甲硫咪唑和左甲状腺素可能分别触发TSH阻断性自身抗体(TBAb)和甲状腺刺激性自身抗体(TSAb)的主导地位。结论:医师应警惕甲状腺功能低下自发转变为甲状腺功能亢进的现象,或反之亦然,一部分自身免疫性甲状腺疾病患者。甲状腺功能的反复评估以及TBAb和TSAb的测量对于鉴定这种罕见的临床实体非常有价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号